Story | Jul 11, 2014 | 12:20 PM
A collection of news and information related to Gilead Sciences Inc. published by this site and its partners.
Top Gilead Sciences Inc. Articles see all
Displaying items 1-5
Story | Jul 15, 2014 | 7:22 AM(Reuters) - Johnson & Johnson reported higher-than-expected quarterly results on sizzling sales of its new Olysio treatment for hepatitis C, but company officials cautioned the pill will lose steam later this year as newer rivals come to market.
Story | Jul 8, 2014 | 8:54 AM
SINGAPORE (Reuters) - Singapore sovereign investor Temasek Holdings wants to increase its holdings in China's financial services and technology sectors, banking on the long-term growth prospects of the world's second largest economy. Temasek Holdings Pte...
Story | Jul 5, 2014
Sovaldi is used to treat and cure hepatitis C infection by inhibiting its replication. It has an effective cure rate on approximately 90 percent of the patients. The problem is that the cost of treating a person with Sovaldi is $84,000 for the 12 week...
Story | Jun 16, 2014 | 10:00 AM